Zhou L, Li H, Guo W, Feng L, Hu J, Liu J
Front Physiol. 2025; 15:1412235.
PMID: 39764381
PMC: 11701052.
DOI: 10.3389/fphys.2024.1412235.
Harsch B, Borkowski K, Walker R, Pedersen T, Newman J, Shearer G
bioRxiv. 2024; .
PMID: 39026807
PMC: 11257534.
DOI: 10.1101/2024.07.11.603001.
Watanabe S, da Costa Souza F, Kusumoto I, Shen Q, Nitin N, Lein P
Prostaglandins Leukot Essent Fatty Acids. 2024; 202:102622.
PMID: 38954932
PMC: 11613899.
DOI: 10.1016/j.plefa.2024.102622.
Sosnowski D, Jamieson K, Gruzdev A, Li Y, Valencia R, Yousef A
Am J Physiol Heart Circ Physiol. 2022; 323(4):H670-H687.
PMID: 35985007
PMC: 9512117.
DOI: 10.1152/ajpheart.00217.2022.
Wan D, Morisseau C, Hammock B, Yang J
Molecules. 2022; 27(1).
PMID: 35011515
PMC: 8747065.
DOI: 10.3390/molecules27010283.
Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia.
Sari I, Okten H, Aktan C, Cihan E
J Med Biochem. 2020; 39(4):428-435.
PMID: 33312058
PMC: 7710375.
DOI: 10.5937/jomb0-27745.
Changes in erythrocyte membrane epoxyeicosatrienoic, dihydroxyeicosatrienoic, and hydroxyeicosatetraenoic acids during pregnancy.
Somani S, Zeigler M, Fay E, Leahy M, Bermudez B, Totah R
Life Sci. 2020; 264:118590.
PMID: 33069736
PMC: 7755749.
DOI: 10.1016/j.lfs.2020.118590.
Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin.
Walsh S, Reep D, Alam S, Washington S, Al Dulaimi M, Lee S
Reprod Sci. 2020; 27(12):2158-2169.
PMID: 32557282
PMC: 7606383.
DOI: 10.1007/s43032-020-00234-2.
Oxylipin Profiling of Alzheimer's Disease in Nondiabetic and Type 2 Diabetic Elderly.
Morris J, Piccolo B, John C, Green Z, Thyfault J, Adams S
Metabolites. 2019; 9(9).
PMID: 31491971
PMC: 6780570.
DOI: 10.3390/metabo9090177.
Role of oxylipins in cardiovascular diseases.
Nayeem M
Acta Pharmacol Sin. 2018; 39(7):1142-1154.
PMID: 29877318
PMC: 6289399.
DOI: 10.1038/aps.2018.24.
Two Pools of Epoxyeicosatrienoic Acids in Humans: Alterations in Salt-Sensitive Normotensive Subjects.
Elijovich F, Milne G, Brown N, Laniado-Schwartzman M, Laffer C
Hypertension. 2017; 71(2):346-355.
PMID: 29279315
PMC: 5764817.
DOI: 10.1161/HYPERTENSIONAHA.117.10392.
Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A receptor and plasma oxylipins.
Hanif A, Edin M, Zeldin D, Morisseau C, Falck J, Ledent C
Prostaglandins Other Lipid Mediat. 2017; 131:83-95.
PMID: 28890385
PMC: 5635996.
DOI: 10.1016/j.prostaglandins.2017.09.001.
Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A, Edin M, Zeldin D, Morisseau C, Falck J, Nayeem M
PLoS One. 2017; 12(3):e0174137.
PMID: 28328948
PMC: 5362206.
DOI: 10.1371/journal.pone.0174137.
Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.
Hanif A, Edin M, Zeldin D, Morisseau C, Falck J, Nayeem M
PLoS One. 2017; 12(1):e0169584.
PMID: 28056085
PMC: 5215949.
DOI: 10.1371/journal.pone.0169584.
The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-Life.
Zhang Y, Chu C, Wang S, Chen L, Lu J, Kong X
PLoS One. 2016; 11(10):e0165496.
PMID: 27780226
PMC: 5079577.
DOI: 10.1371/journal.pone.0165496.
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Jichova S, Kopkan L, Huskova Z, Dolezelova S, Neckar J, Kujal P
J Hypertens. 2016; 34(10):2008-25.
PMID: 27428043
PMC: 5510029.
DOI: 10.1097/HJH.0000000000001029.
Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.
Fan F, Ge Y, Lv W, Elliott M, Muroya Y, Hirata T
Front Biosci (Landmark Ed). 2016; 21(7):1427-63.
PMID: 27100515
PMC: 5064940.
DOI: 10.2741/4465.
The role of epoxyeicosatrienoic acids in the cardiovascular system.
Yang L, Maki-Petaja K, Cheriyan J, McEniery C, Wilkinson I
Br J Clin Pharmacol. 2015; 80(1):28-44.
PMID: 25655310
PMC: 4500322.
DOI: 10.1111/bcp.12603.
Inside epoxyeicosatrienoic acids and cardiovascular disease.
Tacconelli S, Patrignani P
Front Pharmacol. 2014; 5:239.
PMID: 25426071
PMC: 4226225.
DOI: 10.3389/fphar.2014.00239.
14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.
Falck J, Koduru S, Mohapatra S, Manne R, Atcha K, Atcha R
J Med Chem. 2014; 57(16):6965-72.
PMID: 25119815
PMC: 4148164.
DOI: 10.1021/jm500262m.